Nuclera’s Key Account Manager shares how their eProtein Discovery system is propelling rapid recombinant protein optimization and its utilization in drug discovery.

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

EV Resources has confirmed high-grade antimony samples from first assays at its newest potential near-term production asset ...

Oxytocin receptor (Oxtr) signaling influences complex social behaviors in diverse species, including social monogamy in prairie voles. How Oxtr regulates specific components of social attachment ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its ...

Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...

Integral Metals Corp. (the "Company" or "Integral") is pleased to provide an update on the field program completed in 2024 at the Burntwood Project in Manitoba. The program focused on advancing the ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to ...

Honey Badger Silver Inc. (TSXV:TUF)(OTCQB:HBEIF) (”Honey Badger” or the “Company”) is pleased to announce that based on ...

This week’s Bulls N’ Bears Big Hits examines some notable drill intercepts revealed on the ASX, including Tanami Gold’s 3.80m ...